H.R.7790: Infant Formula Supplemental Appropriations Act, 2022

About This Bill

  • Introduced May 17, 2022
  • Latest Major Action May 19, 2022

Bill Versions

Bill Summary

Infant Formula Supplemental Appropriations Act, 2022 This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States. Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 39 statements associated with H.R.7790.

Bill Actions

Date Description
May 19, 2022
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 374.
May 19, 2022
Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time. (Legislative Day 5/17/2022).
May 18, 2022
On passage Passed by the Yeas and Nays: 231 - 192 (Roll no. 220).
May 18, 2022
Considered as unfinished business.
May 18, 2022
Mrs. Hinson moved to recommit to the Committee on Appropriations.
May 18, 2022
Considered under the provisions of rule H. Res. 1124.
May 18, 2022
On passage Passed by the Yeas and Nays: 231 - 192 (Roll no. 220). (text: CR H5158)
May 18, 2022
Considered as unfinished business. (consideration: CR H5165-5166)
May 18, 2022
Mrs. Hinson moved to recommit to the Committee on Appropriations. (text: CR H5163)
May 18, 2022
Considered under the provisions of rule H. Res. 1124. (consideration: CR H5158-5163)
May 18, 2022
Motion to reconsider laid on the table Agreed to without objection.
May 18, 2022
On motion to recommit Failed by the Yeas and Nays: 202 - 218 (Roll no. 219).
May 18, 2022
POSTPONED PROCEEDINGS - At the conclusion of debate on the Hinson motion to recommit, the Chair put the question on agreeing to the motion and by voice vote announced that the noes had prevailed. Mrs. Hinson demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
May 18, 2022
The previous question on the motion to recommit was ordered pursuant to clause 2(b) of rule XIX.
May 18, 2022
The previous question was ordered pursuant to the rule.
May 18, 2022
DEBATE - The House proceeded with one hour of debate on H.R. 7790.
May 18, 2022
Rule provides for consideration of H.R. 350, H.R. 7688 and H.R. 7790. Provides for one of hour of general debate and one motion to recommit for each bill. Resolution also provides for en bloc suspension authority.
May 18, 2022
Rule H. Res. 1124 passed House.
May 17, 2022
Rules Committee Resolution H. Res. 1124 Reported to House. Rule provides for consideration of H.R. 350, H.R. 7688 and H.R. 7790. Rule provides for consideration of H.R. 350, H.R. 7688, and H.R. 7790. Provides for one of hour of general debate and one motion to recommit for each bill. Resolution also provides for en bloc suspension authority.
May 17, 2022
Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 17, 2022
Rules Committee Resolution H. Res. 1124 Reported to House. Rule provides for consideration of H.R. 350, H.R. 7688 and H.R. 7790. Provides for one of hour of general debate and one motion to recommit for each bill. Resolution also provides for en bloc suspension authority.
May 17, 2022

Introduced in the House by Rosa DeLauro (D-Conn.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page